LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will serve on the International Finance Panel at BioContact 2007 on October 3, 2007 in Quebec City
News | 10. 03. 2007
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.